AbbVie Inc. (ABBV) to Present at the 40th Annual J.P. Morgan Healthcare Conference

2w
1m read
Summary

AbbVie to Present at the 40th Annual J.P. Morgan Healthcare Conference AbbVie (NYSE: ABBV) will participate in the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022. Members of AbbVie’s executive leadership team will present virtually at 2:45 p.m. CT, including Robert A. Michael, vice chairman, finance and commercial operations and chief financial officer, Michael E. Severino, M.D., vice chairman and president, and Jeffrey R. Stewart, executive vice president, chief commercial officer. A live audio webcast of the presentation will be accessible through AbbVie’s Investor Relations website at investors.abbvie.com. About AbbVie AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow.

Article Preview

AbbVie to Present at the 40th Annual J.P. Morgan Healthcare Conference

AbbVie (NYSE: ABBV) will participate in the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022. Members of AbbVie’s executive leadership team will present virtually at 2:45 p.m. CT, including Robert A. Michael, vice chairman, finance and commercial operations and chief financial officer, Michael E. Severino, M.D., vice chairman and president, and Jeffrey R. Stewart, executive vice president, chief commercial officer.

A live audio webcast of the presentation will be accessible through AbbVie’s Investor Relations website at investors.abbvie.com....

Read the full article @ Marijuana Stocks